ELYM - Eliem Therapeutics, Inc. Market Valuation

Eliem Therapeutics (ELYM) develops advanced therapies for mental disorders and epilepsy. The asset's price action on the GURU.Markets platform illustrates the impact of patent protection and strict FDA regulations, with the market indicator standing at 0.34. The business is currently optimizing its collaboration with external laboratories to enable flexible drug testing. Simultaneously, international tensions are hindering reagent supplies and restricting global scientific exchange.

ELYM Eliem Therapeutics, Inc.: Market Valuation in the range 07/04/2022 - 10/03/2024

ELYM (Eliem): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart Eliem|ELYM - Price Target Chart

- market capitalization statistics:

Market Valuation Eliem Therapeutics Inc.|ELYM - Total Enterprise Value

- business book valuation details:

Net Assets per Single Share Eliem Therapeutics|ELYM - Company Net Assets|Market Value to Book Value Ratio eliemtx.com|ELYM - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Eliem Therapeutics|ELYM - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Eliem Therapeutics, Inc.|ELYM - Company Aggregate Debts|Debt to Book Capitalization Ratio Eliem Therapeutics, Inc.|ELYM - Company Long-Term Loans and Borrowings|Company Short-Term Debt Eliem Therapeutics|Quick Ratio eliemtx.com

- business earnings and investment ratios data:

ELYM - Company Net Income|Expected Profit Eliem Therapeutics|ELYM - Price to Earnings Ratio|Forward P/E Multiple eliemtx.com|ELYM - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Eliem Therapeutics Inc.|ELYM - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Eliem Therapeutics|ELYM - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months eliemtx.com|ELYM - Earnings per share increase in current year|Expected earnings per share growth for next year Eliem Therapeutics

- sales and revenue data:

ELYM - Company Total Sales|Projected Sales Volume Eliem Therapeutics|ELYM - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Eliem Therapeutics Inc.

Fundamental company analysis:ELYM (Eliem Therapeutics Inc.)

Product sample of Eliem Therapeutics, Inc.

Investors must evaluate the market weight of Eliem Therapeutics (ELYM) relative to its competitors in the neuropharmacology sector. Market capitalization, calculated as the share price multiplied by the number of outstanding shares, determines the total business value. By analyzing the company's current market value, one can track the market's reaction to breakthroughs in the development of non-addictive epilepsy treatments. This indicator's dynamics reflect capital's confidence in the safety of new technologies, while the long-term trend determines the issuer's fundamental stability.

Key competitors